430 related articles for article (PubMed ID: 33307138)
41. Diagnostic Performance of Serum Asialo-α1-acid Glycoprotein for Advanced Liver Fibrosis or Cirrhosis in Patients with Chronic Hepatitis B or Nonalcoholic Fatty Liver Disease.
Kim SU; Jeon MY; Lim TS
Korean J Gastroenterol; 2019 Dec; 74(6):341-348. PubMed ID: 31870140
[TBL] [Abstract][Full Text] [Related]
42. Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis.
Mózes FE; Lee JA; Selvaraj EA; Jayaswal ANA; Trauner M; Boursier J; Fournier C; Staufer K; Stauber RE; Bugianesi E; Younes R; Gaia S; Lupșor-Platon M; Petta S; Shima T; Okanoue T; Mahadeva S; Chan WK; Eddowes PJ; Hirschfield GM; Newsome PN; Wong VW; de Ledinghen V; Fan J; Shen F; Cobbold JF; Sumida Y; Okajima A; Schattenberg JM; Labenz C; Kim W; Lee MS; Wiegand J; Karlas T; Yılmaz Y; Aithal GP; Palaniyappan N; Cassinotto C; Aggarwal S; Garg H; Ooi GJ; Nakajima A; Yoneda M; Ziol M; Barget N; Geier A; Tuthill T; Brosnan MJ; Anstee QM; Neubauer S; Harrison SA; Bossuyt PM; Pavlides M;
Gut; 2022 May; 71(5):1006-1019. PubMed ID: 34001645
[TBL] [Abstract][Full Text] [Related]
43. An individual patient data meta-analysis to determine cut-offs for and confounders of NAFLD-fibrosis staging with magnetic resonance elastography.
Liang JX; Ampuero J; Niu H; Imajo K; Noureddin M; Behari J; Lee DH; Ehman RL; Rorsman F; Vessby J; Lacalle JR; Mózes FE; Pavlides M; Anstee QM; Harrison SA; Castell J; Loomba R; Romero-Gómez M;
J Hepatol; 2023 Sep; 79(3):592-604. PubMed ID: 37121437
[TBL] [Abstract][Full Text] [Related]
44. High liver stiffness values by transient elastography related to metabolic syndrome and harmful alcohol use in a large Spanish cohort.
Llop E; Iruzubieta P; Perelló C; Fernández Carrillo C; Cabezas J; Escudero MD; González M; Hernández Conde M; Puchades L; Arias-Loste MT; Serra MÁ; Crespo J; Calleja JL
United European Gastroenterol J; 2021 Oct; 9(8):892-902. PubMed ID: 34077628
[TBL] [Abstract][Full Text] [Related]
45. Elastography-based screening for esophageal varices in patients with advanced chronic liver disease.
Paternostro R; Reiberger T; Bucsics T
World J Gastroenterol; 2019 Jan; 25(3):308-329. PubMed ID: 30686900
[TBL] [Abstract][Full Text] [Related]
46. A diagnostic algorithm for assessment of liver fibrosis by liver stiffness measurement in patients with chronic hepatitis B.
Cai YJ; Dong JJ; Wang XD; Huang SS; Chen RC; Chen Y; Wang YQ; Song M; Chen YP; Li Z; Zhou MT; Shi KQ
J Viral Hepat; 2017 Nov; 24(11):1005-1015. PubMed ID: 28419755
[TBL] [Abstract][Full Text] [Related]
47. Transient elastography for screening of liver fibrosis: Cost-effectiveness analysis from six prospective cohorts in Europe and Asia.
Serra-Burriel M; Graupera I; Torán P; Thiele M; Roulot D; Wai-Sun Wong V; Neil Guha I; Fabrellas N; Arslanow A; Expósito C; Hernández R; Lai-Hung Wong G; Harman D; Darwish Murad S; Krag A; Pera G; Angeli P; Galle P; Aithal GP; Caballeria L; Castera L; Ginès P; Lammert F;
J Hepatol; 2019 Dec; 71(6):1141-1151. PubMed ID: 31470067
[TBL] [Abstract][Full Text] [Related]
48. Liver stiffness measurement by transient elastography in clinical practice.
Sporea I; Sirli R; Deleanu A; Popescu A; Cornianu M
J Gastrointestin Liver Dis; 2008 Dec; 17(4):395-9. PubMed ID: 19104699
[TBL] [Abstract][Full Text] [Related]
49. Two-dimensional shear wave elastography for sparing endoscopy screening in patients with HBV-related compensated advanced chronic liver disease.
Yan Y; Xing X; Lu Q; Wang X; Luo X; Yang L
Expert Rev Gastroenterol Hepatol; 2022 Jan; 16(1):89-96. PubMed ID: 34939906
[TBL] [Abstract][Full Text] [Related]
50. MR elastography-based liver fibrosis correlates with liver events in nonalcoholic fatty liver patients: A multicenter study.
Han MAT; Vipani A; Noureddin N; Ramirez K; Gornbein J; Saouaf R; Baniesh N; Cummings-John O; Okubote T; Setiawan VW; Rotman Y; Loomba R; Alkhouri N; Noureddin M
Liver Int; 2020 Sep; 40(9):2242-2251. PubMed ID: 32652744
[TBL] [Abstract][Full Text] [Related]
51. Non-obese patients with nonalcoholic fatty liver disease may use a lower liver stiffness cut-off to assess fibrosis stages.
Shi YW; Wang QY; Zhao XY; Sun YM; Kong YY; Ou XJ; Jia JD; Wu SS; You H
J Dig Dis; 2020 May; 21(5):279-286. PubMed ID: 32336033
[TBL] [Abstract][Full Text] [Related]
52. Noninvasive Diagnosis of Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease.
Pons M; Augustin S; Scheiner B; Guillaume M; Rosselli M; Rodrigues SG; Stefanescu H; Ma MM; Mandorfer M; Mergeay-Fabre M; Procopet B; Schwabl P; Ferlitsch A; Semmler G; Berzigotti A; Tsochatzis E; Bureau C; Reiberger T; Bosch J; Abraldes JG; Genescà J
Am J Gastroenterol; 2021 Apr; 116(4):723-732. PubMed ID: 33982942
[TBL] [Abstract][Full Text] [Related]
53. Optimal liver stiffness measurement values for the diagnosis of significant fibrosis and cirrhosis in chronic liver disease in Singapore.
Chang PE; Hartono JL; Ngai YL; Dan YY; Lim KB; Chow WC
Singapore Med J; 2019 Oct; 60(10):532-537. PubMed ID: 30556091
[TBL] [Abstract][Full Text] [Related]
54. Combining Spleen Diameter and the Baveno VI Criteria Assessed by 2-Dimensional Shear Wave Elastography to Rule Out High-Risk Varices.
Zhang Z; Zhou H; Duan K; Chen F; Zhang J; Sang L; Zhu X; Yu M
Ultrasound Q; 2024 Jun; 40(2):104-110. PubMed ID: 38470974
[TBL] [Abstract][Full Text] [Related]
55. Controlled attenuation parameter reflects steatosis in compensated advanced chronic liver disease.
Piccinni R; Rodrigues SG; Montani M; Murgia G; Delgado MG; Casu S; Stirnimann G; Semmo N; De Gottardi A; Dufour JF; Berzigotti A
Liver Int; 2020 May; 40(5):1151-1158. PubMed ID: 31823449
[TBL] [Abstract][Full Text] [Related]
56. Diagnostic Performance of 2-D Shear-Wave Elastography with Propagation Maps and Attenuation Imaging in Patients with Non-Alcoholic Fatty Liver Disease.
Podrug K; Sporea I; Lupusoru R; Pastrovic F; Mustapic S; Bâldea V; Bozin T; Bokun T; Salkic N; Șirli R; Popescu A; Puljiz Z; Grgurevic I
Ultrasound Med Biol; 2021 Aug; 47(8):2128-2137. PubMed ID: 33985827
[TBL] [Abstract][Full Text] [Related]
57. Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: A systematic review and meta-analysis.
Selvaraj EA; Mózes FE; Jayaswal ANA; Zafarmand MH; Vali Y; Lee JA; Levick CK; Young LAJ; Palaniyappan N; Liu CH; Aithal GP; Romero-Gómez M; Brosnan MJ; Tuthill TA; Anstee QM; Neubauer S; Harrison SA; Bossuyt PM; Pavlides M;
J Hepatol; 2021 Oct; 75(4):770-785. PubMed ID: 33991635
[TBL] [Abstract][Full Text] [Related]
58. Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.
Eddowes PJ; Sasso M; Allison M; Tsochatzis E; Anstee QM; Sheridan D; Guha IN; Cobbold JF; Deeks JJ; Paradis V; Bedossa P; Newsome PN
Gastroenterology; 2019 May; 156(6):1717-1730. PubMed ID: 30689971
[TBL] [Abstract][Full Text] [Related]
59. Using the ELF test, FIB-4 and NAFLD fibrosis score to screen the population for liver disease.
Kjaergaard M; Lindvig KP; Thorhauge KH; Andersen P; Hansen JK; Kastrup N; Jensen JM; Hansen CD; Johansen S; Israelsen M; Torp N; Trelle MB; Shan S; Detlefsen S; Antonsen S; Andersen JE; Graupera I; Ginés P; Thiele M; Krag A
J Hepatol; 2023 Aug; 79(2):277-286. PubMed ID: 37088311
[TBL] [Abstract][Full Text] [Related]
60. Validation of original, expanded Baveno VI, and stepwise & platelet-MELD criteria to rule out varices needing treatment in compensated cirrhosis from various etiologies.
Nawalerspanya S; Sripongpun P; Chamroonkul N; Kongkamol C; Piratvisuth T
Ann Hepatol; 2020; 19(2):209-213. PubMed ID: 31607647
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
